Chordate Medical Holding AB (publ)

Stockholm Stock Exchange CMH.ST

Chordate Medical Holding AB (publ) Gross Profit Margin for the year ending December 31, 2023: 55.17%

Chordate Medical Holding AB (publ) Gross Profit Margin is 55.17% for the year ending December 31, 2023, a 75.75% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.
  • Chordate Medical Holding AB (publ) Gross Profit Margin for the year ending December 31, 2022 was 31.39%, a -85.62% change year over year.
  • Chordate Medical Holding AB (publ) Gross Profit Margin for the year ending December 31, 2021 was 218.26%, a -46.35% change year over year.
  • Chordate Medical Holding AB (publ) Gross Profit Margin for the year ending December 31, 2020 was 406.85%, a 128.57% change year over year.
  • Chordate Medical Holding AB (publ) Gross Profit Margin for the year ending December 31, 2019 was 178.00%, a 3,738.53% change year over year.
Key data
Date Gross Profit Margin Operating Income Margin EBT Margin Net Income Margin
Market news
Stockholm Stock Exchange: CMH.ST

Chordate Medical Holding AB (publ)

CEO Mr. Anders Weilandt
IPO Date Feb. 15, 2022
Location Sweden
Headquarters KistagAngen 20B
Employees 3
Sector Health Care
Industries
Pharmaceuticals
Description

Chordate Medical Holding AB (publ), a medical technology company, develops products and solutions for the treatment of chronic migraine and rhinitis in Sweden. It focuses on the ear-nose and throat area. The company was founded in 2005 and is based in Kista, Sweden.

Similar companies

CLS-B.ST

Clinical Laserthermia Systems AB (publ)

USD 0.28

-7.61%

StockViz Staff

January 15, 2025

Any question? Send us an email